Your browser doesn't support javascript.
loading
3,3'-Diiodothyronine concentrations in hospitalized or thyroidectomized patients: results from a pilot study.
Jonklaas, Jacqueline; Sathasivam, Anpalakan; Wang, Hong; Finigan, David; Soldin, Offie P; Burman, Kenneth D; Soldin, Steven J.
Afiliação
  • Jonklaas J; Division of Endocrinology, Georgetown University, Washington DC.
  • Sathasivam A; Division of Endocrinology, Georgetown University, Washington DC Section of Endocrinology, Medstar Washington Hospital Center.
  • Wang H; Medstar Health Research Institute, Hyattsville, Maryland.
  • Finigan D; Division of Endocrinology, Georgetown University, Washington DC.
  • Soldin OP; Division of Endocrinology, Georgetown University, Washington DC Department of Oncology, National Institutes of Health, Bethesda, Maryland.
  • Burman KD; Section of Endocrinology, Medstar Washington Hospital Center.
  • Soldin SJ; Division of Endocrinology, Georgetown University, Washington DC Department of Laboratory Medicine, National Institutes of Health, Bethesda, Maryland.
Endocr Pract ; 20(8): 797-807, 2014 Aug.
Article em En | MEDLINE | ID: mdl-24518182
ABSTRACT

OBJECTIVE:

To determine if various medical conditions affect the serum concentrations of 3,3'-diiodothyronine (3,3'-T2).

METHODS:

A total of 100 patients who were recruited from a group of inpatients and outpatients with a diverse range of medical conditions, donated a single blood sample that was assayed for thyroid hormone derivatives using liquid-chromatography tandem mass spectrometry (LC-MS/MS). The associations between 3,3'-T2 concentrations and physiologic data and medical conditions were assessed.

RESULTS:

Higher quartiles of 3,3'-T2 concentrations (quartile 1 2.01-7.48, quartile 2 7.74-12.4, quartile 3 12.5-17, quartile 4 17.9-45.8 pg/mL) were associated with decreasing occurrence of critical illness (58%, 11%, 0%, 8%), stroke (29%, 7.7%, 4%, 0%), critical care unit hospitalization (75%, 39%, 8.3 %, 12%), and inpatient status (83%, 42%, 8%, 12%) (all P<.001). The same quartiles were associated with increasing frequency of thyroidectomy (4%, 12%, 17%, 60%). In multivariate analyses, after adjustment for age and sex, inpatient status was associated with decreasing concentrations of 3,3'-T2 (46% decrease for inpatients with 95% confidence interval [CI] 32-57%, P<.0001). Thyroidectomy was associated with increasing concentrations of 3,3'-T2 (29% increase (CI 0.5-66%, P = .049).

CONCLUSION:

We observed associations between inpatient status and reduced 3,3'-T2 concentrations. This appears to be a global change associated with illness, rather than an association with specific medical conditions. We also observed higher 3,3'-T2 concentrations in athyreotic outpatients receiving thyroid-stimulating hormone (TSH) suppression therapy. This demonstrates that there is production of 3,3'-T2 from levothyroxine (LT4) in extrathyroidal tissues. Conversion of thyroxine (T4) to 3,3'-T2 via both triiodothyronine (T3) and reverse triiodothyronine (rT3) pathways may prevent excessive T3 concentrations in such patients.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tireoidectomia / Di-Iodotironinas Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Endocr Pract Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tireoidectomia / Di-Iodotironinas Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Endocr Pract Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2014 Tipo de documento: Article